Xenobiotic

Urology Care Foundation Announces 2024 Research Awards of Distinction

Retrieved on: 
Jeudi, avril 4, 2024
Western University, Research, American Urological Association, Xenobiotic, Translational research, Postdoctoral researcher, Prostate cancer, Environment, Lawson Health Research Institute, Immunology, Committee, Gut microbiota, University, Macrophage, Doctor of Philosophy, Role, Publication, Pediatrics, University of California, Pediatric urology, Division, FACS, Radiation therapy, Society, Michigan Medicine, Nursing

BALTIMORE, April 04, 2024 (GLOBE NEWSWIRE) -- The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association, is pleased to announce the recipients of the 2024 Research Awards of Distinction.

Key Points: 
  • BALTIMORE, April 04, 2024 (GLOBE NEWSWIRE) -- The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association, is pleased to announce the recipients of the 2024 Research Awards of Distinction.
  • "We are optimistic about the future of urologic research with the selection of the recipients of this year’s Urology Care Foundation Research Awards,” said Harris M. Nagler, MD, Urology Care Foundation President.
  • “We are thrilled with the Urology Care Foundation Research Awards of Distinction awardees this year,” said Steven Kaplan, MD, Chair of the AUA’s Research Council.
  • The awardees will be celebrated at the Urology Care Foundation Research Honors Program held at the AUA Annual Meeting in May 2024.

Parental avoidance of toxic exposures could help prevent autism, ADHD in children, new study shows

Retrieved on: 
Jeudi, mars 28, 2024
Pesticide, Sensitivity, Xenobiotic, Collaborative writing, Prevalence, ADHD, Cell, Risk, Inflammation, Patient, SAN, School, Anglo-French Wars, Tissue, Research, Miller, Child, Breast, Virus, University, Wane, Doctor of Philosophy, Pregnancy, Causality, Attention deficit hyperactivity disorder, Gulf War, B cell, EPA, CDC, University of Texas System, Fire, Toxicology, Workforce, Public health, TILT, Spectrum, Family, Histamine, Vaccine

SAN ANTONIO, March 27, 2024 /PRNewswire-PRWeb/ -- Autism and attention deficit hyperactivity disorder (ADHD) may be preventable if parents avoid toxic exposures and adopt interventions such as environmental house calls, according to a published study led by researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio).

Key Points: 
  • The findings build on a 2015 study by UT Health San Antonio that first linked chemical intolerance in patients with the risk of their children developing autism and ADHD.
  • "Up to now, most interventions have been behavioral or medical, after a child is diagnosed."
  • Still, they wrote, "The implications of this study, if confirmed, could be significant for preventive measures and early intervention strategies in families with parental chemical intolerance.
  • And the prevalence of ADHD has risen to one in eight children, also according to the CDC.

Environmental Monitoring: Evaluating Cellular Response Pathways in Complex Mixtures, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Lundi, décembre 5, 2022
Kleiber's law, Pennsylvania State University, Food, Lipid, Unresolved complex mixture, Central nervous system, Workflow, Doctor of Philosophy, Pharmacology, Xenobiotic, Biophysical environment, Research, Respiration (physiology), Toxicology, Assay, Pharmaceutical industry, Medicine

TORONTO, Dec. 5, 2022 /PRNewswire-PRWeb/ -- Cell-based in vitro bioassays have been used in environmental monitoring to detect and quantify the presence of micropollutants in water samples. These assays provide scientists with a rapid, sensitive and cost-effective tool for evaluating the impact that environmental contaminants may have on biological activity.

Key Points: 
  • These assays provide scientists with a rapid, sensitive and cost-effective tool for evaluating the impact that environmental contaminants may have on biological activity.
  • However, the complexity of chemical mixtures in environmental matrices makes it difficult to choose which cellular response pathways to evaluate.
  • In this webinar, the featured speaker will review recent environmental toxicology research that employs an alternative workflow for evaluating water samples.
  • For more information, or to register for this event, visit Environmental Monitoring: Evaluating Cellular Response Pathways in Complex Mixtures .

KalVista Pharmaceuticals Announces Publications in the Journal of Medicinal Chemistry and Xenobiotica for Sebetralstat

Retrieved on: 
Mercredi, octobre 19, 2022
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, U.S. Securities and Exchange Commission, DME, Acid dissociation constant, American Chemical Society, Tmax, Protease, NASDAQ, HAE, Security (finance), Annual report, Plasma kallikrein, Private Securities Litigation Reform Act, Form 10-K, Diabetic retinopathy, Hereditary angioedema, Absorption, Journal of Medicinal Chemistry, Safety, American, Journal, Plasma, Medicinal chemistry, Forward-looking statement, Metabolism, FDA, COVID-19, Risk, Xenobiotic, Toxicology, KALV, Pharmaceutical industry

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced the publication of new sebetralstat data in both the Journal of Medicinal Chemistry and Xenobiotica.

Key Points: 
  • KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced the publication of new sebetralstat data in both the Journal of Medicinal Chemistry and Xenobiotica.
  • The Journal of Medicinal Chemistry article focuses on the medicinal chemistry KalVista conducted that led to the discovery of sebetralstat, with properties optimized for the on-demand treatment of hereditary angioedema (HAE).
  • These foundational papers further demonstrate the promise of sebetralstat for the on-demand treatment of HAE attacks, said Andrew Crockett, Chief Executive Officer of KalVista.
  • Additional details can be found in the manuscripts, which are available at:
    The Journal of Medicinal Chemistry is a biweekly peer-reviewed medical journal published by the American Chemical Society covering research in medicinal chemistry.

Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions at Analytica 2022

Retrieved on: 
Mardi, juin 21, 2022
Health, Other Health, Other Science, Research, Science, Pharmaceutical, Biotechnology, Olive, MALDI, ISO, Chromatography, X-ray, GxP, Lipid, Protein, Metabolomics, Corporation, 3D, Plasma, Spatial, Software, AT, Life, ATR, Solution, Technology, EDS, Compliance, CEO, NIR, Xenobiotic, TGA, Nasdaq, Food, Doctor of Philosophy, Temperature, TG, Drug development, Hertz, MPA, Olive oil, Neuroscience, Biology, Chemistry, SLM, HYPERION, Ownership, Mass spectrometry, Analysis, MALDI imaging, Multimedia, HT, PON, Quality control, Proteomics, Cancer, Research, Microscopy, Optogenetics, Acquisition, 4D, Partnership, CFR, QCL, Cell biology, IonSense, Fine chemical, Ceramic, Microscope, Camera, Medical imaging, Bruker, Analytica

Bruker Corporation (Nasdaq: BRKR) this week displays its high-value scientific instrumentation, software and integrated solutions for applications in materials and energy research, biopharmaceuticals, applied markets, as well as life science and translational research at Analytica 2022 .

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR) this week displays its high-value scientific instrumentation, software and integrated solutions for applications in materials and energy research, biopharmaceuticals, applied markets, as well as life science and translational research at Analytica 2022 .
  • Bruker is committed to providing optimized technological, software, chemistry and biology solutions to enable the success of our customers.
  • Bruker launches the HYPERION II FT-IR / IR Laser Imaging Microscope as a flexible research platform, combining FT-IR microscopy with QCL IR laser imaging.
  • Brukers high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View

Retrieved on: 
Lundi, juin 6, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Life, Experiment, Cell, Research, MALDI, Conference, TME, MALDI imaging, Medical University of South Carolina, Mass spectrometry, Marie Cassidy, Partnership, Disease, Nasdaq, Solution, Multimedia, Artifact, Â, Medical school, Bruker, Therapy, Microscopy, IHC, Tumor microenvironment, CCS, Technology, Lipid, Microgrid, Glycosylation, Cell biology, Pharmacology, Flex, Xenobiotic, Proteomics, Protein, Medical imaging, Fine chemical, Microscope

At the 70th ASMS Conference, Bruker Corporation (Nasdaq: BRKR) announced key innovations for spatial multiomics of tissue and tumor microenvironments (TME).

Key Points: 
  • At the 70th ASMS Conference, Bruker Corporation (Nasdaq: BRKR) announced key innovations for spatial multiomics of tissue and tumor microenvironments (TME).
  • Following Brukers strategic partnership with AmberGen1, key enhancements are introduced for MALDI HiPLEX-IHC mass spectrometry imaging.
  • Using AmberGens MiralysTM antibody-based photocleavable peptide mass tags, highly multiplexed IHC staining and photocleavage of peptide markers fit seamlessly into Brukers IntelliSlide-based automated workflows for MALDI imaging.
  • Novel multiomic imaging enhances spatial high-plex protein imaging with the ability to elucidate metabolic processes in the same tissue section.

Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research

Retrieved on: 
Lundi, avril 11, 2022
Oncology, Health, Medical Devices, Genetics, Research, Science, Biotechnology, Life, Lipid, Plasma, Map, TME, Multimedia, IHC, Microscopy, Tumor microenvironment, Research, HDR, Metastasis, Neoplasm, Sagittal plane, MALDI, Tissue, Nasdaq, Workflow, Cell biology, Solution, Xenobiotic, Protein, Proteomics, Partnership, Medical imaging, Fine chemical, Flex, Bruker

At the AACR Annual Meeting 2022, Bruker Corporation (Nasdaq: BRKR) launched and exhibited unique and novel capabilities for spatial multiomics, single-cell proteomics, and cell-line, tissue and plasma proteomics cancer research.

Key Points: 
  • At the AACR Annual Meeting 2022, Bruker Corporation (Nasdaq: BRKR) launched and exhibited unique and novel capabilities for spatial multiomics, single-cell proteomics, and cell-line, tissue and plasma proteomics cancer research.
  • Dr. Michael L. Easterling, Bruker Director of Imaging Life Sciences Mass Spectrometry, commented: Spatial protein expression mapping can elucidate processes in immuno-oncology, and in TME and metastasis research.
  • Additionally, Bruker demonstrated the new CellScapeTM instrument for high-precision targeted spatial proteomics, recently launched by their Canopy Biosciences division.
  • Applications in cancer biology are abundant and include spatial phenotyping of the diverse tumor and immune cell types in the tumor microenvironment (TME).

Nano-Materials as Photocatalysts for Degradation of Environmental Pollutants: Incorporates Both Theoretical & Practical Aspects - ResearchAndMarkets.com

Retrieved on: 
Lundi, novembre 25, 2019
Science, Environment, Research, Physical sciences, Natural sciences, Chemistry, Photochemistry, Soil contamination, Environmental chemistry, Light, Molecular biology, Photodegradation, Photocatalysis, Xenobiotic, Pollutant

The "Nano-Materials as Photocatalysts for Degradation of Environmental Pollutants" book from Elsevier Science and Technology has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nano-Materials as Photocatalysts for Degradation of Environmental Pollutants" book from Elsevier Science and Technology has been added to ResearchAndMarkets.com's offering.
  • Nano-Materials as Photocatalysts for Degradation of Environmental Pollutants: Challenges and Possibilities contains both practical and theoretical aspects of environmental management using the processes of photodegradation and various heterogeneous catalysts.
  • The book's main focus is on the degradation of harmful pollutants, such as petrochemicals, crude oils, dyes, xenobiotic pharmaceutical waste, endocrine disrupting compounds, and other common pollutants.
  • Includes examples on the degradation of organic pollutants from various sources, e.g., pharmaceuticals, dyes, pesticides, etc.